Treatment with rosuvastatin in patients with hepatitis C
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 12 Feb 2009
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 12 Feb 2009 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 05 Nov 2006 New trial record.